↓ Skip to main content

Autophagy inhibition potentiates the anti-angiogenic property of multikinase inhibitor anlotinib through JAK2/STAT3/VEGFA signaling in non-small cell lung cancer cells

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, February 2019
Altmetric Badge

Mentioned by

twitter
1 X user
reddit
1 Redditor

Citations

dimensions_citation
111 Dimensions

Readers on

mendeley
53 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Autophagy inhibition potentiates the anti-angiogenic property of multikinase inhibitor anlotinib through JAK2/STAT3/VEGFA signaling in non-small cell lung cancer cells
Published in
Journal of Experimental & Clinical Cancer Research, February 2019
DOI 10.1186/s13046-019-1093-3
Pubmed ID
Authors

Lijun Liang, Kaiyuan Hui, Chenxi Hu, Yixuan Wen, Shikun Yang, Panrong Zhu, Lei Wang, Youyou Xia, Yun Qiao, Wen Sun, Jiayan Fei, Ting Chen, Fenghua Zhao, Baocheng Yang, Xiaodong Jiang

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 53 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 53 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 8 15%
Student > Ph. D. Student 7 13%
Student > Bachelor 3 6%
Researcher 3 6%
Student > Postgraduate 2 4%
Other 6 11%
Unknown 24 45%
Readers by discipline Count As %
Medicine and Dentistry 11 21%
Biochemistry, Genetics and Molecular Biology 11 21%
Pharmacology, Toxicology and Pharmaceutical Science 2 4%
Unspecified 1 2%
Philosophy 1 2%
Other 2 4%
Unknown 25 47%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 March 2022.
All research outputs
#20,674,485
of 25,394,764 outputs
Outputs from Journal of Experimental & Clinical Cancer Research
#1,636
of 2,384 outputs
Outputs of similar age
#348,009
of 457,600 outputs
Outputs of similar age from Journal of Experimental & Clinical Cancer Research
#59
of 90 outputs
Altmetric has tracked 25,394,764 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,384 research outputs from this source. They receive a mean Attention Score of 4.8. This one is in the 17th percentile – i.e., 17% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 457,600 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 13th percentile – i.e., 13% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 90 others from the same source and published within six weeks on either side of this one. This one is in the 20th percentile – i.e., 20% of its contemporaries scored the same or lower than it.